{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:15:51Z","timestamp":1789636551470,"version":"4.0.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["GH000371"],"award-info":[{"award-number":["GH000371"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169762","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T14:43:02Z","timestamp":1486996982000},"page":"e0169762","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["First-line antiretroviral drug discontinuations in children"],"prefix":"10.1371","volume":"12","author":[{"given":"Melony","family":"Fortuin-de Smidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene\u00e9","family":"de Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-G\u00fcnter","family":"Technau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehimario U.","family":"Igumbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"ref1","article-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","year":"2015"},{"key":"ref2","article-title":"Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach, 2003 Revision","year":"2004"},{"key":"ref3","article-title":"Antiretroviral therapy of HIV infection in infants and children: towards universal access","year":"2006"},{"key":"ref4","article-title":"Recommendations for a public health approach: 2010 revision","year":"2010"},{"key":"ref5","article-title":"Recommendations for a public health approach","year":"2013"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/00365540701203493","article-title":"Long-term effectiveness of highly active antiretroviral therapy (HAART) in perinatally HIV-infected children in Denmark","volume":"39","author":"L Bracher","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"e96307","DOI":"10.1371\/journal.pone.0096307","article-title":"Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012","volume":"9","author":"C Palladino","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2431-7-13","article-title":"Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa","volume":"7","author":"A Reddi","year":"2007","journal-title":"BMC Pediatr"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1542\/peds.103.4.e47","article-title":"A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team","volume":"103","author":"MW Kline","year":"1999","journal-title":"Pediatrics"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/INF.0b013e3182076864","article-title":"Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy","volume":"30","author":"P Nahirya-Ntege","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref11","article-title":"National Antiretroviral Treatment Guidelines","year":"2004"},{"key":"ref12","article-title":"Guidelines for the Management of HIV in Children","year":"2010"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"18794","DOI":"10.7448\/IAS.16.1.18794","article-title":"Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa","volume":"16","author":"AT Brennan","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"ref14","article-title":"The South African Antiretroviral Treatment Guidelines 2013","year":"2013"},{"key":"ref15","article-title":"Guidelines for the management of HIV-infected children in South Africa","year":"2005"},{"key":"ref16","unstructured":"Kampiire L, Garone D, Giddy J, Rabie H, Wood R, Moultrie H, et al. Substitutions to initial antiretroviral therapy in children in South Africa\u2014The IeDEA\u2014Southern Africa Paediatric Collaboration. 19th International AIDS Conference; 2012; Washington, USA."},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e3280e087e7","article-title":"Lamivudine\/abacavir maintains virological superiority over zidovudine\/lamivudine and zidovudine\/abacavir beyond 5 years in children","volume":"21","author":"H Green","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1086\/339751","article-title":"Abacavir hypersensitivity reaction","volume":"34","author":"RG Hewitt","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"39","key":"ref19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2431-8-39","article-title":"Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center\/nurse-based care","volume":"8","author":"J van Griensven","year":"2008","journal-title":"BMC Pediatr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/QAI.0b013e3182423668","article-title":"Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In Uganda","volume":"59","author":"V Tukei","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/tropej\/fmn080","article-title":"Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India","volume":"55","author":"N Kumarasamy","year":"2009","journal-title":"J Trop Pediatr"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/QAD.0b013e32835c54b8","article-title":"Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa","volume":"27","author":"M Palmer","year":"2013","journal-title":"Aids"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T12:41:28Z","timestamp":1568810488000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169762"}},"subtitle":[],"editor":[{"given":"Abdelwahab","family":"Omri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169762","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}